Log in
NASDAQ:TLSA

Tiziana Life Sciences Stock Forecast, Price & News

$3.82
-0.23 (-5.68 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.60
Now: $3.82
$3.97
50-Day Range
$3.01
MA: $3.91
$4.96
52-Week Range
$0.62
Now: $3.82
$12.17
Volume298,150 shs
Average Volume949,009 shs
Market Capitalization$245.32 million
P/E RatioN/A
Dividend YieldN/A
Beta2.27
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. It also develops Anti IL-6r (TZLS-501), a human anti-interleukin-6 receptor monoclonal antibody for the treatment of IL6-induced inflammation, primarily to treat hospitalized COVID-19 patients with severe respiratory symptoms; and StemPrintER, a multi-gene signature assay intended for use in patients diagnosed with estrogen-receptor positive ER+/HER2 negative breast cancers. The company was founded in 2013 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLSA
CUSIPN/A
CIKN/A
Phone44-20-7495-2379
Employees8

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.09) per share

Profitability

Miscellaneous

Market Cap$245.32 million
Next Earnings DateN/A
OptionableNot Optionable
$3.82
-0.23 (-5.68 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLSA News and Ratings via Email

Sign-up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tiziana Life Sciences (NASDAQ:TLSA) Frequently Asked Questions

How has Tiziana Life Sciences' stock price been impacted by COVID-19 (Coronavirus)?

Tiziana Life Sciences' stock was trading at $3.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TLSA stock has decreased by 3.3% and is now trading at $3.82.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Tiziana Life Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tiziana Life Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Tiziana Life Sciences
.

What price target have analysts set for TLSA?

1 analysts have issued 1-year price targets for Tiziana Life Sciences' stock. Their forecasts range from $11.00 to $11.00. On average, they anticipate Tiziana Life Sciences' stock price to reach $11.00 in the next twelve months. This suggests a possible upside of 188.0% from the stock's current price.
View analysts' price targets for Tiziana Life Sciences
.

Are investors shorting Tiziana Life Sciences?

Tiziana Life Sciences saw a increase in short interest in September. As of September 30th, there was short interest totaling 625,400 shares, an increase of 125.1% from the September 15th total of 277,800 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is currently 0.5 days.
View Tiziana Life Sciences' Short Interest
.

Who are some of Tiziana Life Sciences' key competitors?

What other stocks do shareholders of Tiziana Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Pfizer (PFE), Vaxart (VXRT), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Moderna (MRNA), Enterprise Products Partners (EPD), Novavax (NVAX), Dynavax Technologies (DVAX) and Gilead Sciences (GILD).

Who are Tiziana Life Sciences' key executives?

Tiziana Life Sciences' management team includes the following people:
  • Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA, Founder & Exec. Chairman (Age 48, Pay $284.56k)
  • Dr. Kunwar Shailubhai, CEO, Chief Scientific Officer & Exec. Director (Age 62, Pay $810k)
  • Dr. Andrea Brancale, Scientific Founder
  • Mr. Richard Clarkson Ph.D., Scientific Founder
  • Mr. Andrew Westwell Ph.D., Scientific Founder

When did Tiziana Life Sciences IPO?

(TLSA) raised $10 million in an IPO on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. acted as the underwriter for the IPO.

What is Tiziana Life Sciences' stock symbol?

Tiziana Life Sciences trades on the NASDAQ under the ticker symbol "TLSA."

Who are Tiziana Life Sciences' major shareholders?

Tiziana Life Sciences' stock is owned by many different institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (0.03%).

Which institutional investors are buying Tiziana Life Sciences stock?

TLSA stock was acquired by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

How do I buy shares of Tiziana Life Sciences?

Shares of TLSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tiziana Life Sciences' stock price today?

One share of TLSA stock can currently be purchased for approximately $3.82.

How big of a company is Tiziana Life Sciences?

Tiziana Life Sciences has a market capitalization of $245.32 million. The company earns $-9,320,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Tiziana Life Sciences employs 8 workers across the globe.

What is Tiziana Life Sciences' official website?

The official website for Tiziana Life Sciences is www.tizianalifesciences.com.

How can I contact Tiziana Life Sciences?

Tiziana Life Sciences' mailing address is 3RD FLOOR 11-12 ST. JAMES`S SQUARE, LONDON X0, SW1Y 4LB. The company can be reached via phone at 44-20-7495-2379 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.